Akèy › Maladi Alzheimer › Connecticut
Etid klinik pou Maladi Alzheimer nan Connecticut
12 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan Connecticut.
Vil nan Connecticut
Tèks ofisyèl etid la (Anglè)
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- University of Connecticut Health Center, Farmington
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787Music for Pain and Dementia
- Connecticut Mental Health Clinic, New Haven
Ap rekrite
Laj 50 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07602283Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Yale University, New Haven
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2632, Norwalk
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011745Exploring the Utility of [18F]3F4AP for Demyelination Imaging
- Yale University PET Center, New Haven
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Sep 9, 2026 · NCT06999434A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Yale University, Alzheimer's Disease Research Unit ( Site 1059), New Haven
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Yale University School of Medicine - Section of Cardiology, New Haven
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Yale University School of Medicine, New Haven
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Yale University School of Medicine, New Haven
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157Neurologic Stem Cell Treatment Study
- MD Stem Cells, Westport
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT02795052Evaluation of a Mobile App Program for Coping With Cancer
- Smilow Cancer Hospital, New Haven
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT06923501Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.